Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Test symbols : Ilmn save search
GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study
Published: 2024-03-18 (Crawled : 13:30) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: 0.51%
H: 2.49%
C: 1.37%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: -0.45%
H: 0.55%
C: -0.24%
lung test cancer risk study
Curative Insurance Company Adds GRAIL’s Galleri® Test to Member Benefits for Multi-Cancer Early Detection
Published: 2024-02-01 (Crawled : 20:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: 0.48%
H: 1.56%
C: 1.43%
galleri company test insurance benefits
Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
Published: 2024-01-05 (Crawled : 14:30) - prnewswire.com
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: -2.54%
H: 4.66%
C: 1.87%
disease test cancer collaboration molecular
Validation Data on a Novel Prognostic Test Developed by GRAIL in Stage I Lung Cancer Presented at North America Conference on Lung Cancer
Published: 2023-12-06 (Crawled : 22:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: 1.4%
H: 3.94%
C: 0.58%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: 0.73%
H: 0.06%
C: -1.38%
america lung conference test cancer
Final Results From PATHFINDER Study of GRAIL’s Multi-Cancer Early Detection Blood Test Published in The Lancet
Published: 2023-10-05 (Crawled : 00:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: 0.04%
H: 1.31%
C: 0.77%
test lancet blood results study
Point32Health and GRAIL Expand Pilot Access to Galleri® Multi-Cancer Early Detection Blood Test
Published: 2023-09-28 (Crawled : 15:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: -2.17%
H: 2.66%
C: 1.49%
galleri test blood pilot
FirstHealth of the Carolinas to Offer GRAIL’s Galleri®, a Multi-Cancer Early Detection Blood Test
Published: 2023-04-18 (Crawled : 15:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: 0.88%
H: 0.0%
C: -1.6%
galleri test blood
Henry Ford Health First in Michigan to Offer Multi-Cancer Early Detection Blood Test
Published: 2022-09-22 (Crawled : 18:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: -1.04%
H: 0.57%
C: -1.33%
blood ford test health cancer
Grail and National Health Service (NHS) England Complete Enrollment of 140,000 Participants in Largest Study of Multi-Cancer Early Detection Test
Published: 2022-07-18 (Crawled : 14:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: 0.71%
H: 2.62%
C: -1.71%
test service health study
Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
Published: 2022-06-22 (Crawled : 11:00) - biospace.com/
MYGN | $18.48 -0.11% -0.11% 430K
|
Health Technology
|
| O: -1.28%
H: 4.91%
C: 3.47%
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: -4.93%
H: 0.0%
C: 0.0%
research test
GRAIL and England’s National Health Service (NHS) Present Trial Design for Largest Study of Multi-Cancer Early Detection Test at ASCO Annual Meeting
Published: 2022-06-06 (Crawled : 16:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: 2.16%
H: 0.32%
C: -4.79%
test service health trial asco designation
GRAIL Announces Strategic Collaboration With AstraZeneca to Develop Companion Diagnostic Tests to Enable the Treatment of Early-Stage Cancer
Published: 2022-06-02 (Crawled : 17:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: -0.03%
H: 5.85%
C: 5.7%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
treatment collaboration diagnostic cancer test
GRAIL Announces Collaboration With U.S. Department of Veterans Affairs and the Veterans Health Foundation to Evaluate Galleri® Multi-Cancer Early Detection Test
Published: 2022-05-31 (Crawled : 17:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: -1.52%
H: 0.13%
C: -5.77%
galleri test collaboration health
European Infectious Disease Diagnostics Industry to 2031 - Technological Advancements in Molecular Techniques and Infectious Diagnostic Tests Presents Opportunities
Published: 2022-05-20 (Crawled : 11:00) - prnewswire.com
TMO | News | $548.38 0.66% 0.29% 1.5M
|
Health Technology
|
| O: 3.64%
H: 0.0%
C: 0.0%
QGEN | $41.22 3.05% 0.0% 1.2M
|
Health Technology
|
| O: 2.51%
H: 0.0%
C: 0.0%
BIO | $280.13 0.14% 0.0% 180K
|
Health Technology
|
| O: 3.64%
H: 1.64%
C: -0.75%
BDX | $233.88 -0.1% 0.0% 770K
|
Health Technology
|
| O: 1.57%
H: 0.42%
C: -0.04%
A | $133.91 0.89% 0.0% 850K
|
Health Technology
|
| O: 3.19%
H: 1.25%
C: 0.89%
QGEN | $41.22 3.05% 0.0% 1.2M
|
Health Technology
|
| O: 2.51%
H: 0.0%
C: 0.0%
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: 2.6%
H: 0.49%
C: -0.55%
disease diagnostic diagnostics molecular test
Global Genetic Testing Market Report 2022-2026: Genetic Testing Market Witnesses Sluggish Growth during COVID-19, Set to Record Exponential Growth Post-COVID
Published: 2022-03-24 (Crawled : 19:00) - prnewswire.com
TMO | News | $548.38 0.66% 0.29% 1.5M
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: 0.0%
QGEN | $41.22 3.05% 0.0% 1.2M
|
Health Technology
|
| O: 0.52%
H: 0.23%
C: -1.36%
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 0.55%
H: 0.14%
C: -1.96%
LH M | $203.07 0.79% 0.0% 680K
|
Health Services
|
| O: 0.57%
H: 0.5%
C: 0.36%
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
QGEN | $41.22 3.05% 0.0% 1.2M
|
Health Technology
|
| O: 0.52%
H: 0.23%
C: -1.36%
NTRA | News S | $88.65 3.95% 3.8% 1.1M
|
Health Services
|
| O: 4.14%
H: 0.0%
C: 0.0%
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.18%
covid-19 genetic report growth set market test covid
Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
Published: 2022-03-15 (Crawled : 08:00) - prnewswire.com
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
europe genomic test cancer
Insights on the NGS Sample Preparation Global Market to 2026 - Rising Direct-to-Consumer Testing Presents Opportunities
Published: 2022-02-07 (Crawled : 21:00) - prnewswire.com
TMO | News | $548.38 0.66% 0.29% 1.5M
|
Health Technology
|
| O: -2.16%
H: 0.0%
C: 0.0%
BIO | $280.13 0.14% 0.0% 180K
|
Health Technology
|
| O: -1.42%
H: 0.0%
C: 0.0%
A | $133.91 0.89% 0.0% 850K
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
PACB | $1.55 0.0% 8.8M
|
Health Technology
|
| O: -1.32%
H: 2.44%
C: 1.15%
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: -1.33%
H: 1.35%
C: 0.67%
test
GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri® Multi-Cancer Early Detection Blood Test
Published: 2021-12-06 (Crawled : 13:00) - biospace.com/
ALHC | $5.0 -3.85% -4.0% 830K
|
|
| O: -7.69%
H: 0.0%
C: 0.0%
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: -4.2%
H: 0.0%
C: 0.0%
partnership blood test cancer
Organ Transplant Diagnostics Market, 2031 - Emergence of Nucleic Acid Amplification Testing (NAAT) & Growing Focus on Molecular HLA Typing
Published: 2021-11-25 (Crawled : 12:00) - prnewswire.com
QGEN | $41.22 3.05% 0.0% 1.2M
|
Health Technology
| Email alert
Add to watchlist
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
| Email alert
Add to watchlist
CDNA | $8.17 -1.69% -1.71% 480K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
| Email alert
Add to watchlist
DGX | News | $130.09 1.29% 0.0% 1.7M
|
Health Services
| Email alert
Add to watchlist
QGEN | $41.22 3.05% 0.0% 1.2M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $548.38 0.66% 0.29% 1.5M
|
Health Technology
| Email alert
Add to watchlist
LH M | $203.07 0.79% 0.0% 680K
|
Health Services
| Email alert
Add to watchlist
BIO | $280.13 0.14% 0.0% 180K
|
Health Technology
| Email alert
Add to watchlist
diagnostic test molecular growing diagnostics merge
GRAIL Receives New York State Approval for Galleri Multi-Cancer Early Detection Blood Test
Published: 2021-09-20 (Crawled : 15:00) - biospace.com/
ILMN | $120.28 2.43% 2.37% 1.1M
|
Health Technology
|
| O: -1.42%
H: 2.11%
C: -0.61%
blood test cancer approval
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.